Inventiva S.A.(IVA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,530 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
IVA Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Inventiva S.A. (IVA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IVA at 29.4/100 on a 32-signal composite quality model, placing it at rank #2,530 of 2,961 stocks — the bottom half of the AI-ranked universe. Top institutional holders of IVA by reported 13-F value include Caligan Partners, Samsara BioCapital, Paradigm Biocapital Advisors, based on the most recent SEC filings. IVA trades on the Nasdaq exchange and files with the SEC under CIK 1756594. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IVA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Inventiva S.A. directly from SEC EDGAR. Inventiva S.A.'s 13F Pro composite quality score has ranged between 28 and 29 since 2026, currently 29.4 — a stable long-term trajectory across 47 quarterly and live scoring snapshots.
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-47.4% YoYTotal Assets
+71.0% YoY| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $9.2M -47.4% | $17.5M +43.5% | $12.2M +190.4% | $4.2M +1027.4% | $372.0K -94.7% | $7.0M |
| Total Assets | $119.0M +71.0% | $69.6M -40.0% | $116.0M -4.9% | $122.0M -12.2% | $138.9M +143.9% | $57.0M |
Get alerted when IVA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Inventiva S.A. including:
Top Institutional Holders of IVA
Caligan Partners LP
$30.9M8,163,191 shSamsara BioCapital, LLC
$23.9M6,314,805 shParadigm Biocapital Advisors LP
$15.1M4,000,000 shAndera Partners
$13.7M3,633,181 shADAR1 Capital Management, LLC
$13.6M3,606,656 shMILLENNIUM MANAGEMENT LLC
$13.3M3,512,174 shNantahala Capital Management, LLC
$10.2M2,686,393 shTrails Edge Capital Partners, LP
$10.0M2,657,997 shFRANKLIN RESOURCES INC
$10.0M2,642,611 shSquadron Capital Management LLC
$9.2M2,435,000 sh
| Fund | Value | Shares |
|---|---|---|
| Caligan Partners LP | $30.9M | 8,163,191 |
| Samsara BioCapital, LLC | $23.9M | 6,314,805 |
| Paradigm Biocapital Advisors LP | $15.1M | 4,000,000 |
| Andera Partners | $13.7M | 3,633,181 |
| ADAR1 Capital Management, LLC | $13.6M | 3,606,656 |
| MILLENNIUM MANAGEMENT LLC | $13.3M | 3,512,174 |
| Nantahala Capital Management, LLC | $10.2M | 2,686,393 |
| Trails Edge Capital Partners, LP | $10.0M | 2,657,997 |
| FRANKLIN RESOURCES INC | $10.0M | 2,642,611 |
| Squadron Capital Management LLC | $9.2M | 2,435,000 |
Companies Similar to IVA
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
ProQR Therapeutics N.V.
AYTU BIOPHARMA, INC
Evommune, Inc.
C4 Therapeutics, Inc.
KESTRA MEDICAL TECHNOLOGIES, LTD.
ASSEMBLY BIOSCIENCES, INC.
Maze Therapeutics, Inc.
BioAge Labs, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put IVA on your watchlist
Track score changes the day Inventiva S.A. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is IVA a good stock to buy?
13F Pro's AI-powered analysis of Inventiva S.A. (IVA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IVA are available on the IVA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. IVA is classified as a small company.
Which hedge funds own IVA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IVA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Inventiva S.A.'s investment landscape.